AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-158930728/takeda-tandemact-approved-emea.html" title="Facts and information about Takeda's Tandemact approved by EMEA.(European Medicines Agency)(Takeda Pharmaceutical)(drug approval Tandemact)(Brief article)">Takeda's Tandemact approved by EMEA.(European Medicines Agency)(Takeda Pharmaceutical)(drug approval Tandemact)(Brief article)</a>

Close Set up an RSS feed that alerts you when new articles from Pharma Marketletter are available.

Frequently asked questions about RSS feeds

Takeda's Tandemact approved by EMEA.(European Medicines Agency)(Takeda Pharmaceutical)(drug approval Tandemact)(Brief article)

Pharma Marketletter

| January 29, 2007 | COPYRIGHT 2009 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Osaka, Japan-based Takeda Pharmaceutical says that it has been granted European marketing authorization for the diabetes treatment Tandemact (pioglitazone HCl and glimepride HCl). The agent is intended for the treatment of patients with type 2 diabetes mellitus who show intolerance to metformin or for whom metformin is contraindicated and who are already being treated with a combination of the two active ingredients.

Tandemact was filed with the European Medicines Agency (EMEA) by the company's European unit, Takeda Global Research and Development Center (TGRD) in July 2005, and was the subject of a positive opinion from the EMEA's Committee for Medicinal Products for…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Santhera Pharmaceuticals, of Liestal, Switzerland, and Takeda Pharmaceutical...: Newspaper article from: BioWorld International August 22, 2007 700+ words
Santhera Pharmaceuticals, of Liestal, Switzerland, and Takeda Pharmaceutical Co., of Osaka, Japan, said the European Medicines Agency (EMEA) has accepted the filing of the marketing authorization application for Santhera's lead compound...


Takeda withdraws application for ramelteon.(Takeda Pharmaceutical Company...: Newspaper article from: Pharma Marketletter October 6, 2008 700+ words
Japan's Takeda has withdrawn its centralized Marketing Authorization application to the European Medicines Agency (EMEA) for ramelteon 4mg and 8mg tablets. In its official letter, the company stated that the decision was based on its current...


Takeda submits MAA application for ramelteon.(Takeda Pharmaceutical Company...: Newspaper article from: Pharma Marketletter March 26, 2007 700+ words
...drugmaker Takeda has submitted a marketing authorization application for its drug candidate, ramelteon, to the European Medicines Agency (EMEA) for the treatment of primary insomnia. Ramelteon works by selectively targeting two melatonin receptors in the...


A Five Year Analysis of Takeda Pharmaceutical Co Ltd Including Information...: Press release article from: Business Wire December 23, 2005 700+ words
...announced the addition of Takeda Pharmaceutical Co Ltd Deals Briefing...offering. Description Takeda Pharmaceutical Co Ltd Deals briefing...of the 48 deals made by Takeda Pharmaceutical Co Ltd and its subsidiaries...


London Symphony Orchestra and Takeda Pharmaceutical Company Launch the 7th...: News wire article from: JCN Newswires September 20, 2006 700+ words
...20, 2006 - (JCN Newswire) - Takeda Pharmaceutical Company Limited ("Takeda...highly successful relationship with Takeda Pharmaceutical Company supports our concerts worldwide...partnership with Takeda." About Takeda Pharmaceutical Takeda Pharmaceutical, located...


Takeda Pharmaceutical Company Limited - Financial and Strategic Analysis Review.: Press release article from: M2 Presswire May 6, 2009 700+ words
...companiesandmarkets.com: Takeda Pharmaceutical Company Limited - Financial...com adds new report: Takeda Pharmaceutical Company Limited - Financial...Strategic Analysis Review Takeda Pharmaceutical Company Limited - Financial...


Takeda Pharmaceutical, Galaxy Biotech to Sign Licensing Agreement for HuL2G7,...: Magazine article from: JCNN News Summaries July 12, 2006 700+ words
...Japan, July 12, 2006 - (JCN) - Takeda Pharmaceutical has signed a licensing agreement...the agreement announced July 10, Takeda Pharmaceutical will licensed to exclusively develop...manufacture, and sell HuL2G7 worldwide. Takeda Pharmaceutical will make an upfront payment of...


Takeda Pharmaceutical Company Limited - SWOT Analysis.: Press release article from: M2 Presswire January 14, 2009 700+ words
...companiesandmarkets.com: Takeda Pharmaceutical Company Limited - SWOT Analysis...companiesandmarkets.com adds new report: Takeda Pharmaceutical Company Limited - SWOT Analysis This Takeda Pharmaceutical Company Limited Company Profile...


Q1 2007 Takeda Pharmaceutical Company Limited Earnings Conference Call - Final.: News wire article from: Fair Disclosure Wire July 31, 2006 700+ words
...fiscal year ending March 2007 of the Takeda Pharmaceutical Company Ltd. The conference call...AND IR CORPORATE COMMUNICATIONS, TAKEDA PHARMACEUTICAL CO. LTD: Thank you very much...fiscal year ending March 2007 of the Takeda Pharmaceutical Company Ltd. I am Hirofumi Inoue...


Takeda Pharmaceutical, Hitachi Jointly Establish New Information System Company...: Magazine article from: JCNN News Summaries February 21, 2006 700+ words
...Feb 20, 2006 - (JCN) - Takeda Pharmaceutical and Hitachi jointly announced...outsourcing services to Takeda Pharmaceutical. Hitachi retains a 66...in the new company while Takeda Pharmaceutical holds the remaining 34...

For more facts and information, see all results

Source: HighBeam Research, Takeda's Tandemact approved by EMEA.(European Medicines...

The AccessMyLibrary advertising network includes: